DK3554501T3 - Dexmedetomidin eller medetomidin til anvendelse i behandling af separationsangst hos kæledyr - Google Patents
Dexmedetomidin eller medetomidin til anvendelse i behandling af separationsangst hos kæledyr Download PDFInfo
- Publication number
- DK3554501T3 DK3554501T3 DK17828942.7T DK17828942T DK3554501T3 DK 3554501 T3 DK3554501 T3 DK 3554501T3 DK 17828942 T DK17828942 T DK 17828942T DK 3554501 T3 DK3554501 T3 DK 3554501T3
- Authority
- DK
- Denmark
- Prior art keywords
- medetomidine
- dexmedetomidine
- pets
- treatment
- separation anxiety
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 208000000810 Separation Anxiety Diseases 0.000 title 1
- HRLIOXLXPOHXTA-NSHDSACASA-N dexmedetomidine Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CN=C[N]1 HRLIOXLXPOHXTA-NSHDSACASA-N 0.000 title 1
- 229960004253 dexmedetomidine Drugs 0.000 title 1
- HRLIOXLXPOHXTA-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CN=C[N]1 HRLIOXLXPOHXTA-UHFFFAOYSA-N 0.000 title 1
- 229960002140 medetomidine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20165960 | 2016-12-13 | ||
| PCT/FI2017/050880 WO2018109272A1 (en) | 2016-12-13 | 2017-12-12 | Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3554501T3 true DK3554501T3 (da) | 2021-07-19 |
Family
ID=60957335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17828942.7T DK3554501T3 (da) | 2016-12-13 | 2017-12-12 | Dexmedetomidin eller medetomidin til anvendelse i behandling af separationsangst hos kæledyr |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20200069650A1 (da) |
| EP (1) | EP3554501B1 (da) |
| JP (1) | JP7065871B2 (da) |
| KR (2) | KR20190096376A (da) |
| CN (1) | CN110072524A (da) |
| AU (1) | AU2017378203B2 (da) |
| DK (1) | DK3554501T3 (da) |
| ES (1) | ES2879298T3 (da) |
| HR (1) | HRP20211310T1 (da) |
| HU (1) | HUE055565T2 (da) |
| LT (1) | LT3554501T (da) |
| MX (1) | MX389589B (da) |
| PL (1) | PL3554501T3 (da) |
| PT (1) | PT3554501T (da) |
| RU (1) | RU2759726C2 (da) |
| SI (1) | SI3554501T1 (da) |
| WO (1) | WO2018109272A1 (da) |
| ZA (1) | ZA201904591B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202107367SA (en) | 2016-12-31 | 2021-08-30 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| ES3004544T3 (en) | 2018-06-27 | 2025-03-12 | Bioxcel Therapeutics Inc | Film formulations containing dexmedetomidine and methods of producing them |
| US20240024288A1 (en) | 2019-07-19 | 2024-01-25 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| AU2022239873A1 (en) | 2021-03-19 | 2023-11-02 | Orion Corporation | Tasipimidine formulations and use thereof |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI864570A0 (fi) * | 1986-11-11 | 1986-11-11 | Farmos Oy | Terapeutiskt anvaendbar foerening. |
| JP4438256B2 (ja) | 2001-06-29 | 2010-03-24 | 味の素株式会社 | 動伴侶動物における問題行動を防止するための医薬組成物および方法 |
| EP3305281A1 (en) | 2009-05-15 | 2018-04-11 | Recro Pharma, Inc. | Sublingual dexmedetomidine compositions and methods of use thereof |
| EP2906213B1 (en) * | 2012-10-15 | 2018-01-03 | Orion Corporation | A veterinary method of alleviating noise aversion |
-
2017
- 2017-12-12 DK DK17828942.7T patent/DK3554501T3/da active
- 2017-12-12 EP EP17828942.7A patent/EP3554501B1/en active Active
- 2017-12-12 KR KR1020197020353A patent/KR20190096376A/ko not_active Ceased
- 2017-12-12 US US16/468,707 patent/US20200069650A1/en not_active Abandoned
- 2017-12-12 JP JP2019551751A patent/JP7065871B2/ja active Active
- 2017-12-12 RU RU2019121690A patent/RU2759726C2/ru active
- 2017-12-12 WO PCT/FI2017/050880 patent/WO2018109272A1/en not_active Ceased
- 2017-12-12 HR HRP20211310TT patent/HRP20211310T1/hr unknown
- 2017-12-12 HU HUE17828942A patent/HUE055565T2/hu unknown
- 2017-12-12 KR KR1020247019196A patent/KR20240096833A/ko active Pending
- 2017-12-12 ES ES17828942T patent/ES2879298T3/es active Active
- 2017-12-12 CN CN201780076704.9A patent/CN110072524A/zh active Pending
- 2017-12-12 AU AU2017378203A patent/AU2017378203B2/en active Active
- 2017-12-12 MX MX2019006773A patent/MX389589B/es unknown
- 2017-12-12 PT PT178289427T patent/PT3554501T/pt unknown
- 2017-12-12 PL PL17828942T patent/PL3554501T3/pl unknown
- 2017-12-12 SI SI201730829T patent/SI3554501T1/sl unknown
- 2017-12-12 LT LTEPPCT/FI2017/050880T patent/LT3554501T/lt unknown
-
2019
- 2019-07-12 ZA ZA2019/04591A patent/ZA201904591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3554501B1 (en) | 2021-06-09 |
| MX389589B (es) | 2025-03-20 |
| MX2019006773A (es) | 2019-08-22 |
| CN110072524A (zh) | 2019-07-30 |
| KR20240096833A (ko) | 2024-06-26 |
| EP3554501A1 (en) | 2019-10-23 |
| RU2759726C2 (ru) | 2021-11-17 |
| ZA201904591B (en) | 2025-10-29 |
| RU2019121690A3 (da) | 2021-04-07 |
| RU2019121690A (ru) | 2021-01-15 |
| ES2879298T3 (es) | 2021-11-22 |
| AU2017378203B2 (en) | 2022-12-08 |
| JP7065871B2 (ja) | 2022-05-12 |
| CA3046286A1 (en) | 2018-06-21 |
| HUE055565T2 (hu) | 2021-11-29 |
| AU2017378203A1 (en) | 2019-07-25 |
| PT3554501T (pt) | 2021-07-05 |
| KR20190096376A (ko) | 2019-08-19 |
| PL3554501T3 (pl) | 2021-12-06 |
| NZ755354A (en) | 2024-11-29 |
| SI3554501T1 (sl) | 2021-09-30 |
| JP2020500944A (ja) | 2020-01-16 |
| LT3554501T (lt) | 2021-07-12 |
| HRP20211310T1 (hr) | 2021-11-26 |
| WO2018109272A1 (en) | 2018-06-21 |
| US20200069650A1 (en) | 2020-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3562486T3 (da) | Anvendelse af sublingual dexmedetomidin til behandling af agitation | |
| IL248519A0 (en) | Bioceramic compositions and biomodulatory uses thereof | |
| DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
| DK3127300T3 (da) | Håndtering af nic-krypterede flows til at migrere gæster eller opgaver | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3504187T3 (da) | Anvendelse af pridopidin til behandling af funktionel tilbagegang | |
| DK3125875T3 (da) | Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande | |
| EP3402486C0 (en) | CCX168 FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHY | |
| DK3172227T3 (da) | Molekyler der selektivt aktiverer regulatoriske t-celler til behandlingen af autoimmune sygdomme | |
| DK3185957T3 (da) | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | |
| EP3540346A4 (en) | WATER PURIFIER | |
| DK3799885T3 (da) | Neutralisering af hæmmende veje i lymfocytter | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| DK2945642T3 (da) | Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme | |
| DK3307296T3 (da) | Timp2 til anvendelse til behandling af aldringsassocierede tilstande | |
| DK3042559T3 (da) | Anordning til bekæmpelse af varroa-miden i biyngel | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3114235T3 (da) | Fremgangsmåde til bestemmelse af risiko for 5-fluorouracil-toksicitet | |
| IL258478B (en) | Extended use zirconium silicate compositions and methods of use thereof | |
| DK3157522T3 (da) | Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste | |
| HUE063528T2 (hu) | Anti-CD40 antitestek alkalmazása lupus nephritis kezelésére | |
| EP3305291A4 (en) | USES OF BENZIMIDAZOLE DERIVATIVE FOR NURSING ACID BREAK |